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Antiviral proteins that recognize pathogen-specific
or aberrantly located molecular motifs are perfectly
positioned to act as pattern-recognition receptors
and signal to the immune system. Here we in-
vestigated whether the interferon-induced viral
restriction factor tetherin (CD317/BST2), which is
known to inhibit HIV-1 particle release by physically
tethering virions to the cell surface, has such a
signaling role. We find that upon restriction of
Vpu-defective HIV-1, tetherin acts as a virus sensor
to induce NFkB-dependent proinflammatory gene
expression. Signaling requires both tetherin’s extra-
cellular domain involved in virion retention and
determinants in the cytoplasmic tail, including an
endocytic motif, although signaling is independent
of virion endocytosis. Furthermore, recruitment of
the TNF-receptor-associated factor TRAF6 and
activation of the mitogen-activated protein kinase
TAK1 are critical for signaling. Human tetherin’s
ability to mediate efficient signaling may have arisen
as a result of a five amino acid deletion that
occurred in hominids after their divergence from
chimpanzees.
INTRODUCTION
Tetherin is a broadly acting antiviral membrane protein that
blocks the release of diverse mammalian viruses from the
surface of infected cells and reduces retroviral pathogenesis
in vivo (Liberatore and Bieniasz, 2011; Martin-Serrano and
Neil, 2011). Tetherin partitions into assembling virions, cross-
linking them to the plasma membrane (PM) by virtue of its
unique topology. The potential importance of tetherin in innate
antiviral immunity is underscored by examples of virally en-
coded proteins that counteract its activity, the prototype being
the accessory gene product Vpu of human immunodeficiency
virus type 1 (HIV-1) (Le Tortorec et al., 2011). Vpu interacts
with human tetherin in infected cells, blocking its transit to
viral assembly sites on the PM (Dube´ et al., 2011; Kueck and
Neil, 2012; Schmidt et al., 2011) and promoting its endoso-
mal degradation (Agromayor et al., 2012; Janvier et al., 2011).Cell Host &Among the primate lentiviruses, the species-specific target-
ing of tetherin is widespread, even though the vpu gene is
restricted to a subset of simian immunodeficiency viruses
(SIVs). In SIVs in which Vpu is absent, the Nef accessory
protein performs the role, and the sensitivity of primate
tetherins to SIV Nefs is determined by a five amino acid
patch in the protein’s cytoplasmic tail that was deleted after
hominids and chimpanzees diverged (Jia et al., 2009; Zhang
et al., 2009).
Accumulating evidence indicates that tetherin imposes a
powerful selective pressure on primate lentiviruses and that
its counteraction is essential for HIV/SIV replication and spread
in vivo. Adaptation of the SIVcpz Vpu to target human tetherin
efficiently is a feature of the major group (Group M) of HIV-1
that is responsible for the HIV/AIDS pandemic, but not the
separate SIVcpz species jumps that led to the N, O, and P
groups that have remained geographically restricted (Sauter
et al., 2009). Zoonotic spread of the Vpu() SIV of sooty
mangabeys (SIVsm) to become HIV-2, whose Nef protein
cannot target human tetherin, resulted in tetherin counteraction
developing in the envelope protein (Env) (Le Tortorec and Neil,
2009). Furthermore, a similar adaptation in Env has been
observed in macaques experimentally infected with a Nef-
defective SIVmac that reverted to pathogencity (Serra-Moreno
et al., 2011).
While tetherin potently blocks cell-free virion release, its ability
to block cell-to-cell transfer is controversial, and where it has
been observed, weak (Casartelli et al., 2010; Jolly et al., 2010).
In cultured primary CD4+ T cells, Vpu-defective viruses have
evenbeen observed to spread faster through the culture in a teth-
erin-dependent manner (Jolly et al., 2010). These superficially
paradoxical observations between viral replication in culture
and the evolutionary conservation of tetherin counteraction in
primate lentiviruses suggest that tetherin’s contribution to
the antiviral immune response is not limited to physical inhibition
of virion release. Interestingly, prior to its identification as an
antiviral factor, tetherin (BST2) was identified as an inducer of
NFkB activation in a whole-genome transfection screen (Mat-
suda et al., 2003). Furthermore, tetherin has been implicated
as a regulator of Toll-like receptor (TLR) function in plasmacytoid
dendritic cells through the activation of the inhibitory leukocyte
receptor ILT7 (Cao et al., 2009). We therefore hypothesized
that tetherin, like the retroviral restriction factor TRIM5a, might
act as a sensor for the presence of viral infection coupled to its
antiviral activity (Pertel et al., 2011). In this study we tested this
hypothesis.Microbe 12, 633–644, November 15, 2012 ª2012 Elsevier Inc. 633
Figure 1. Tetherin Induces NFkB-Dependent Responses upon Overexpression, Crosslinking, and Restriction of Virion Release
(A) Fold activation of a firefly-luciferase NFkB reporter gene in 293 cells transiently cotransfected with tetherin, MAVS, or control YFP vectors.
(B) Fold activation of the same reporter in 293 or 293THN cells treated for 24 hr with a rabbit anti-tetherin polyclonal serum and a secondary anti-rabbit
antibody.
(C) Time course of endogenous IkB degradation and IKKa/b phosphorylation in 293THN cells after antibody crosslinking.
(D and E) (D) Fold increases in NFkB-reporter activity in 293 and 293THN cells transfected with wild-type and Vpu() HIV-1 proviruses and (E) fold changes in
Cxcl10 mRNA levels compared to YFP transfection calculated relative to Gapdh by qRT-PCR.
(F and G) NFkB-reporter fold activation in 293 and 293THN cells transfected with GFP-fused Ebolavirus VP40 expression vector (F) or MLV provirus or derivatives
(MLVDPY and MLVDPY/p6) (G). Fold changes relative to 293 cells transfected with YFP control (A, D–G) or 293 nontreated cells (B). *p > 0.05 and ***p > 0.001 as
determined by two-tailed t test. All error bars represent ±SEM of three independent experiments.
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Restriction of Enveloped Virus Particle Release by
Human Tetherin Induces NFkB-Dependent Gene
Expression
We first sought to confirm whether tetherin was capable
of inducing NFkB activation when overexpressed. Transient
transfection of human tetherin into 293 cells potently induced
the activation of an NFkB-dependent firefly luciferase reporter
construct to levels similar to those seen with the MAVS/IPS1/
Cardif component of the cytoplasmic viral RNA-sensing pathway
(Takeuchi and Akira, 2010), confirming the previous observa-
tion from the genomic screen (Matsuda et al., 2003) (Figure 1A).
We then examined whether crosslinking of cell-surface tetherin
was capable of transducing a similar signal in 293 cells stably ex-
pressing human tetherin (293THN), but not vector control 293
cells. While background level of reporter gene activation in the
two cell types was less than 1.5-fold, crosslinking the surface
protein with a polyclonal antibody resulted in a 10-fold increase
in NFkB-dependent luciferase expression in tetherin-expressing
cells (Figure 1B) and led to the concomitant phosphorylation of
IKKa/b and degradation of IkB (Figure 1C). This suggested that
clustering of tetherin might mediate a proinflammatory signal
upon restriction of enveloped virus release. Consistent with
this, budding and assembly of HIV-1 lacking the tetherin counter-
measure Vpu (Neil et al., 2008), or encoding a point mutant of634 Cell Host & Microbe 12, 633–644, November 15, 2012 ª2012 ElsVpu (A14L) that is defective for interaction with tetherin (Vigan
and Neil, 2010), specifically induced enhanced NFkB reporter
activation in cells stably expressing tetherin while the wild-type
virus did not, correlating with physical particle release (Figure 1D
and see Figures S1A and S1B online). Furthermore, consistent
with the activation of the reporter gene, we could observe induc-
tion of the mRNA of a representative NFkB-dependent target
gene, the proinflammatory chemokine CXCL10, in the same cells
(Figure 1E).
Since tetherin restricts the release of a variety of mammalian
viruses, we then sought to determine whether other tetherin-
sensitive viral particles could activate the NFkB reporter. We
observed similar reporter activation by producing tetherin-sensi-
tive filoviral-like particles (VLPs) derived from the Ebolavirus
matrix protein VP40 (Jouvenet et al., 2009; Neil et al., 2007) (Fig-
ure 1F and Figure S1C). Furthermore, since previous studies
have demonstrated that tetherin restricts the release of fully
assembled virions that have separated their membranes from
that of the host cell, we then examined whether assembly-
defective retroviral particles could trigger tetherin-dependent
NFkB activation. For this we used a murine leukemia virus
(MLV) provirus, or derivatives with mutations in the p12Gag late-
domain sequence (MLVDPY) that facilitates virion budding and
membrane scission by recruiting the ESCRT-pathway (Martin-
Serrano and Neil, 2011). As expected, wild-type MLV release
was restricted in 293THN cells, whereas MLVDPY release wasevier Inc.
Cell Host & Microbe
Tetherin Senses HIV Assemblydefective in both cell types (Figure S1D). Production of wild-
type MLV virions triggered enhanced NFkB reporter activity in
293THN cells, but the assembly-defective MLVDPY did not (Fig-
ure 1G). Interestingly, MLVDPY/p6, where the p12 late domain
has been replaced with one derived from HIV-1 p6gag, recovered
both virion production and the enhanced NFkB reporter activa-
tion in 293THN cells (Figure 1G and Figure S1D). Therefore acti-
vation of NFkB in tetherin-expressing cells requires full virion
assembly and scission of the cellular and virion membranes.
Together these data show that in cells constitutively expressing
tetherin, the restriction of enveloped virion release triggers a
proinflammatory response.
Tetherin-Sensitive HIV-1 Mutants Induce Enhanced
Proinflammatory Cytokine Expression in Infected CD4+
T Cells
We then asked whether tetherin-mediated restriction of HIV-1
particle release in primary human CD4+ T cells would induce
proinflammatory gene expression. Purified CD4+ T cells from
three donors were infected with wild-type HIV-1, Vpu() HIV-1,
or HIV-1 encoding tetherin binding-defective mutant Vpu-A14L
that retains all other known Vpu functions. As expected, cell-
free virus release of the Vpu mutant HIV-1s was impaired
compared towild-type in all donors (Figures 2A and 2B). Interest-
ingly, cultures infected with both Vpu() and Vpu-A14L HIV-1
mutants led to increased levels of mRNAs for proinflammatory
cytokines CXCL10 and IL-6 (Figure 2C). In two of the donors,
increased levels of Ifnb mRNA were also detected (Figure 2C).
Furthermore, these increases in mRNA levels were reflected in
significant increases in the concentrations of CXCL10, IL-6,
and bioactive type-1 IFN in the supernatant (Figure 2D). The
induction of type 1 IFN expression implied the activation of
interferon regulatory factors (IRFs) 3 or 7 in addition to NFkB.
In parallel reporter gene experiments to those described above,
however, tetherin overexpression, crosslinking, or Vpu() HIV-1
assembly could not activate an IFNb-promoter-luciferase re-
porter construct in 293THN cells. Neither did we observe any
induction of ifnbmRNA or phosphorylation of IRF3 in this system
(Figures S2A–S2C). However, in CD4+ T cells we could detect
IRF3 phosphorylation after 48 hr of HIV-1 infection. In contrast
to the induction of the NFkB-dependent Cxcl10 mRNA in
T cells or tetherin-mediated reporter gene activation in 293THN
cells, this IRF3 phosphorylation and the concomitant IFNb ex-
pression could be suppressed by inhibition of the TLR3 adaptor
TRIF (Figures S2D–S2G), suggesting that tetherin-mediated viral
retention may additionally augment viral recognition by other
host PRRs. Therefore, to confirm the tetherin dependency of
all these data, we transduced primary CD4+ T cells with lentiviral
vectors encoding shRNA hairpins against tetherin (shTHN) or an
irrelevant target (GFP) 24 hr prior to infection with the above
viruses. As expected, shTHN transduction reduced surface teth-
erin levels and rescued the release of Vpu() and Vpu-A14L
mutant viruses to wild-type levels (Figures S2H and S2I). It also
concomitantly reduced both Cxc10 and Ifnb mRNA induction
in the same cells (Figure 2E), demonstrating that proinflamma-
tory gene expression induced by Vpu() HIV-1 in target cells is
tetherin dependent. We thus provide evidence that interaction
of tetherin with HIV-1 induces proinflammatory gene expression
consistent with a direct signaling role.Cell Host &Structural Determinants of Tetherin-Mediated Signaling
We then mapped the determinants of NFkB activation in human
tetherin. The primary sequence of the tetherin cytoplasmic tail
does not affect the protein’s antiviral activity (data not shown).
However, we reasoned that the cytoplasmic tail likely played
a role in signaling and screened a series of tetherin cytoplasmic
tail mutants for NFkB-dependent reporter gene activation (Fig-
ure 3A). This revealed defects in signaling that mapped to the
conserved YXY site that mediates tetherin’s endocytic recycling
to the PM (Rollason et al., 2007), as well as an adjacent CRV
motif. Mutations encompassing the two membrane-proximal
lysine residues, which can serve as ubiquitylation targets (Le Tor-
torec et al., 2011), were also defective for signaling. However,
these alanine mutants appeared immature in SDS-PAGE, sug-
gesting a trafficking defect, and mutation of the individual lysine
residues to arginine preserved signaling capacity (Figure S3A).
Stable cell lines expressing tetherin Y6,8A and 10-12A failed to
mediate reporter-gene activation in response to Vpu() HIV-1,
yet they retained potent viral particle restriction, consistent
with the hypothesis that thesemotifs are required for transducing
a signal initiated by virion retention (Figures 3B). By contrast, the
antiviral activity of tetherin depends upon the structural integrity
of its extracellular domain, particularly in its C-terminal GPI-
linked membrane anchor, its dimeric state, and its extracellular
coiled-coil domain (Perez-Caballero et al., 2009). Mutations in
the coiled coil (L123P), the extracellular cysteine residues that
mediate dimerization, or deletion of the GPI anchor, all of which
render tetherin unable to inhibit viral release, reduced the ability
of tetherin to promote NFkB-reporter gene activation both in
transient transfections and in stably expressing cells transfected
with tetherin-sensitive and -insensitive HIV-1 (Figure 3C and Fig-
ure S3B). Thus tetherin’s ability to mediate NFkB activation
requires the extracellular determinants essential for multimeriza-
tion and virion retention, and cytoplasmic tail motifs required to
transduce a signal dependent on this retention.
Tetherin-Mediated Signaling Is Independent of Virion
Endocytosis
Tetherin-mediated retention of Vpu() HIV-1 virions leads to their
accumulation in late endosomal compartments (Martin-Serrano
and Neil, 2011). The implication of the YXYmotif, which has been
previously shown to interact with both AP1 and AP2 clathrin
adaptors, suggested that endocytosis of virions might be
required for signaling. Consistent with this, a lower proportion
of cells exhibited distinct endosomal accumulations of HIV-1
Gag-GFP in 293THN-Y6,8A compared to 293THN 24 hr post-
transfection (48% versus 74%), suggesting that the YXY motif
may play a role in virion uptake (Figures 4A and 4B). Recent
evidence suggests that YXY mutants of tetherin are impaired
but not fully defective for endocytosis (Lau et al., 2011), poten-
tially accounting for this partial phenotype. However, siRNA
depletion of AP2m1 reduced endosomal virion localization to
levels comparable to the parental 293 cells, similar to the ex-
pected result observed by cotransfecting a dominant inhibitory
mutant S34N of the early endocytic GTPase Rab5a (Neil et al.,
2008). As a control, the proportion of transfected cells with ob-
servable endosomal Gag-GFP was unchanged when using the
dominantly active mutant, Rab5a(Q79L), with Gag-GFP VLPs
accumulating in the lumen of swollen Rab5+ve endosomes.Microbe 12, 633–644, November 15, 2012 ª2012 Elsevier Inc. 635
Figure 2. Restriction of Tetherin-Sensitive HIV-1 Mutant Release from Infected CD4+ T Cells Induces Proinflammatory Gene Expression
(A and B) Purified CD4+ T cells from three independent donors were infected with the indicated virus at anmoi of 5, and 48 hr later viral release was determined by
infection of HeLa-TZM reporter cell lines (A) and western blot of cell lysates (B).
(C) Total RNA from three biological replicates of parallel cultures infected as in (A) was analyzed for Cxcl10, IL6, and Ifnb mRNA levels relative to Gapdh by
qRT-PCR.
(D) Protein levels in the supernatants from (A) were determined by ELISA (CXCL10 and IL-6) or by HEK-Blue indicator cells (IFNb).
(E) Activated CD4+ T cells were transduced with lentiviral vectors encoding short hairpin against GFP (sh-control) or against tetherin (shTHN) 24 hr prior to
infection as in (A). Total RNA from three biological replicates of parallel cultureswas analyzed forCxcl10 and IfnbmRNA levels relative toGapdh by qRT-PCR. Fold
changes relative to noninfected cells (C and E). *p > 0.05, **p > 0.01, and ***p > 0.001 as determined by two-tailed t test. All error bars represent ±SEM.
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Figure 3. Determinants of Tetherin-Medi-
ated Signaling
(A) A series of alanine scan mutants in the cyto-
plasmic tail of human tetherin were assessed for
the ability to induce NFkB-Luc reporter activation
in transiently transfected 293 cells. Mutations en-
compassing residues 17–21 of the cytoplasmic tail
were discounted due to aberrant localization (data
not shown), and further mutants are presented in
Figure S3. Error bars are ±SEM.
(B) 293 cells stably expressing the Y6,8A and
10-12A mutants were further assessed for their
ability to induce NFkB-Luc reporter activation
upon transfection with wild-type or Vpu() HIV-1
proviral plasmids. Infectious virus release was
determined on HeLa-TZM indicator cells and
physical particle yield analyzed by western blot of
cell lysates and pelleted supernatants using an
anti-p24 monoclonal antibody.
(C)Mutations in the extracellular domain of tetherin
defective for inhibiting viral release (cysteine-less
3CA, the coiled-coil point mutant L123P, or a
truncation lacking the GPI anchor) were assayed
for NFkB-Luc reporter activation in transfected
293 cells. Fold changes ±SEM relative to 293 cells
transfected with YFP control (B and C).
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induced NFkB-reporter activation in 293THN cells. As expected,
Vpu() HIV-1 induced an increase in reporter activation com-
pared to wild-type virus. However, in the presence of AP2m1
depletion or Rab5a(S34N) overexpression, Vpu() virus-induced
signaling was significantly increased in 293THN cells (Figures 4C
and 4D). These data suggest that while the YDYCRV motif is
essential for virion-induced signaling, virion uptake is not, and
blockade of their delivery to late endosomes potentiates reporter
gene expression. Together, they suggest that tetherin-depen-
dent accumulation of virions on the cell surface triggers NFkB
activation.
TAK1 Activation and Recruitment of TRAF6 Are
Required for Tetherin-Mediated Signaling
Proinflammatory activation of NFkB from TNF receptors and
membrane-associated and cytosolic PRRs is mediated through
the mitogen-activated protein kinase TAK1 (MAP3K7) (Skaug
et al., 2009). We therefore asked whether there were similarities
between tetherin-mediated NFkB activation and that of other
viral PRRs. Depletion of TAK1 by siRNA completely abolished
the NFkB-reporter gene activation induced by tetherin overex-
pression or Vpu() HIV-1 in 293THN cells (Figure 5A), implicatingCell Host & Microbe 12, 633–644, Nthe activation of TAK1 as critical in teth-
erin-mediated signaling. TAK1 activation
by host PRRs depends on the upstream
recruitment of family members of the
TNF-receptor-associated factor (TRAF)
family of E3 ubiquitin ligases, particularly
TRAF2 and TRAF6, and the E2 ligase
Ubc13 (UBE2N), which act to polymerize
K63-linked ubiquitin chains (Skaug et al.,
2009). RNAi depletion of these factorssimilarly inhibited tetherin-mediated NFkB reporter activity (Fig-
ure 5B). Interestingly, while the human tetherin cytoplasmic
tail has a putative TRAF6 consensus-binding motif (PXEXX-
aromatic/acidic), disruption of this sequence by mutagenesis
did not impair tetherin signaling (Figure 3). However, tetherin
could be specifically coimmunoprecipitated with an HA-tagged
TRAF6 dependent on the presence of the YCRV motif that is
conserved in ape tetherins and partially overlaps the protein’s
endocytic motif (Figure 5C and Figure S4), although whether
this interaction is direct is unknown. Furthermore, mutation of
residues 10–12 (RVP) retained TRAF6 interaction despite losing
signaling activity, indicating that in conjunction with the RNAi
data, TRAF6 is necessary but not sufficient for tetherin signaling.
These data suggest that virion aggregation by tetherin leads to
YDYCRV-dependent recruitment of a signaling complex that
includes TRAF6 to induce TAK1-dependent NFkB activation
when viral release is restricted.
Signaling Is a Feature of Human and Chimpanzee
Tetherins and Is Augmented by a Hominid-Specific
Deletion in the Tetherin Cytoplasmic Tail
Tetherin’s antiviral activity is conserved in mammals. Surpris-
ingly, however, murine and old world monkey tetherins showedovember 15, 2012 ª2012 Elsevier Inc. 637
Figure 4. Inhibition of Virion Endocytosis Enhances Tetherin-Dependent NFkB Activation
(A and B) The indicated cell lines were transfected with an HIV-1 Gag-GFP expression vector, with or without either pretreatment with control siRNA or AP2m1 for
48 hr or cotransfection with Cherry-FP fused mutants of Rab5a (S34N or Q79L). Twenty-four hours later, the cells were fixed and ten random fields were
enumerated on the basis of whether transfected cells displayed plasma-membrane only Gag-GFP localization or PM and distinct endsomal accumulation (A) and
imaged by confocal microscopy (B).
(C and D) The effects of AP2m1 siRNAs and Che-Rab5a-S34N on HIV-1 proviral-induced NFkB reporter gene activation were determined as above. Fold changes
relative to 293 cells transfected with YFP control with error bars representing ±SEM.
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potently restricting HIV-1 particle release (Figure 6A). Chim-
panzee tetherin (cpz-tetherin), while capable of inducing reporter
gene activation, was less potent than the human protein (Fig-
ure 6A). Informed by ourmutagenesis studies (Figure 3), we iden-
tified three regions of species-specific changes between the
cytoplasmic tails of human, chimpanzee, and rhesus tetherins
that might contribute to the differences in signaling. First, a major
difference between human and other primate proteins is the
presence of a G/DDIWK motif that is absent in Homo sapiens.
The tryptophan in this motif is under high evolutionary positive
selection and determines the sensitivity of primate tetherins to
the Nef proteins of SIVs (Lim et al., 2010). Second, while the
two tyrosine residues in the YXYXXV endocytic motif are highly
conserved throughout mammalian evolution, differences occur
between humans/chimpanzees and old world monkeys at posi-
tions 9–11, a region we have identified as critical to human teth-638 Cell Host & Microbe 12, 633–644, November 15, 2012 ª2012 Elserin’s signaling ability. Both the C9 (Gupta et al., 2009; Lim et al.,
2010) and R10 (Gupta et al., 2009; McNatt et al., 2009) positions
have been previously ascribed to be under positive selection
throughout primate evolution. Third, in human and chimpanzee
tetherins a repeated glycine-isoleucine pair extends the tetherin
transmembrane helix, and is an important determinant of sensi-
tivity to HIV-1 Vpu (McNatt et al., 2009). A further difference
between human, chimpanzee, and rhesus encompasses an
ubiquitination site (STS) (Tokarev et al., 2011), although our
alanine mutagenesis suggests that this motif is not important.
Transfection of increasing amounts of hu- and cpz-tetherin
plasmids revealed that at low expression levels human tetherin
was markedly more efficient at inducing NFkB-reporter activa-
tion, and high levels of the chimpanzee protein never achieved
parity (Figure 6B). Deletion of the DDIWK motif enhanced cpz-
tetherin-mediated NFkB reporter gene activation to the level of
human protein, and its reintroduction into the human proteinevier Inc.
Figure 5. Mechanistic Aspects of Tetherin-Mediated Signaling
(A) Depletion of TAK1 by siRNA in either 293 cells transfected with tetherin, or in 293 and 293THN cells transfected with Vpu() HIV-1 proviral plasmid, abolishes
NFkB-Luc reporter activation but has no effect on Gag production.
(B) Impairment of NFkB-Luc reporter activation by siRNA depletion of TRAF6, TRAF2, or Ubc13 in 293 cells transfected with tetherin.
(C) Coimmunoprecipitation of tetherin and tetherin(10-12A) but not tetherin Y6,8A with HA-TRAF6 in transiently transfected 293 cells. All error bars are ±SEM of
three independent experiments.
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either expression, restriction of Vpu() HIV-1 release, or TRAF6
association (Figure 6B and Figure S5). Therefore efficiency of
NFkB activation between hu-tetherin and cpz-tetherin appears
to be an evolutionarily recent acquisition that has coincided
with the deletion of a motif known to act as a target for SIV teth-
erin countermeasures.
We then turned our attention to rh-tetherin. In rhesus
macaques, position 9 is polymorphic (either a C or an R), and
neither variant could mediate NFkB-reporter activity. Similarly,
a C9R change in human tetherin had no effect on signaling ability
(data not shown). Introduction of KM-to-RV changes into rh-teth-
erin did not endow it with any signaling activity, but the corre-
sponding RV-to-KM swap in human tetherin severely reduced
its NFkB-reporter induction without compromising antiviral
activity, confirming that these residues are necessary in human,
but not sufficient to explain the lack of rhesus signaling
(Figure 6B). To determine the minimal changes in rh-tetherin
that could confer signaling activity, we constructed chimerasCell Host &between rh-tetherin and cpz-tetherin. Again all proteins were
capable of restricting virion release. Surprisingly, only a chimera
bearing the cpz-tetherin cytoplasmic tail including the additional
TM-domain GI residues (rh-cpz 31) recovered any NFkB activa-
tion (Figure 6B). These results suggest multiple context-depen-
dent adaptations have resulted in human tetherin’s signaling
capacity. First, changes in the previously identified YXYXXV
motif in conjunction with a lengthened TM domain, which itself
may be expected to alter the conformation of the cytoplasmic
tail, are required to confer levels of signaling activity seen in
cpz-tetherin. Second, deletion of the DDIWK motif in human
ancestors greatly enhanced the efficiency of this activity.
DISCUSSION
In this study we have demonstrated that human tetherin can
transduce a proinflammatory signal when it restricts virion pro-
duction. This appears to be coupled to cell-surface aggregation
of virions, resulting in the TAK1-dependent activation of NFkBMicrobe 12, 633–644, November 15, 2012 ª2012 Elsevier Inc. 639
Figure 6. Tetherin’s Signaling Activity Is
a Recent Acquisition in Primate Evolution
(A) NFkB-Luc reporter activation in 293 cells
transiently transfected with murine, rhesus, AGM,
chimpanzee, and human tetherins and their
respective ability to restrict Vpu-defective virus
release.
(B) Alignment of the cytoplasmic tails of primate
tetherins with regions differing from human shown
in gray. Species-specific changes were made
according to major differences indicated at
positions 1, 2, and 3 and tested for NFkB-Luc
reporter activation at varying expression levels. All
error bars represent ±SEM of three independent
experiments.
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Tetherin Senses HIV Assemblyand subsequent cytokine production. Importantly, we could
show that tetherin-sensitive mutants of HIV-1 induce enhanced
proinflammatory cytokine production in infected CD4+ T cells.
This suggests that the action of tetherin senses enveloped virus
assembly, and that the infected cell responds by releasing medi-
ators that can attract innate and adaptive immune cells to the
site of infection to augment the antiviral response. Thus we sug-
gest that in the context of an infected cell, a budding enveloped
virion constitutes a pathogen-associated molecular pattern, and
in addition to physically restricting virion release, tetherin acts as
the cognate PRR.
Mechanistically, tetherin signaling has similarities to TLRs
and other viral PRRs, including another retroviral restriction
factor, TRIM5a (Pertel et al., 2011; Skaug et al., 2009; Takeuchi
and Akira, 2010). NFkB is activated through the upstream
kinase TAK1. PRR-mediated TAK1 activation depends on the
association of its accessory factors TABs 1–3 with free polyubi-
quitin chains bearing K63 linkages, which in turn are synthe-
sized by the concerted action of TRAF E3 ligases with E2
complex of Ubc13/UBE1. TRAFs, particularly TRAFs 2, 3, 5,
and 6, play key roles in signal transduction from a host of proin-
flammatory cell-surface receptors, and TRAF2 and TRAF6 are
also essential cofactors for cytoplasmic RIG-I-like helicases.640 Cell Host & Microbe 12, 633–644, November 15, 2012 ª2012 Elsevier Inc.We found that RNAi-mediated knock-
down of TRAF2, TRAF6, and Ubc13 in-
hibited tetherin activation of NFkB, for
which TAK1 was also essential. Further-
more we could observe an interaction
between tetherin and TRAF6. While the
human tetherin cytoplasmic tail contains
a predicted TRAF6 binding site, we
found that this interaction was actually
determined by the adjacent endocytic
motif YDYCRV. How the YDYCRV motif
recruits TRAF6, and how this relates to
its endocytic function, remains to be
determined. While signaling is dependent
on this signal, which appears also to
play a partial role in virion internaliza-
tion, blockade of virion uptake itself by
AP2m siRNAs or Rab5(S34N) potentiates
NFkB activation. Since these treatments
do not affect tetherin’s physical antiviralactivity per se, these data strongly suggest that large surface
virion accumulations are the primary trigger of tetherin-medi-
ated signaling.
TRAF6 recruitment is not sufficient to explain tetherin-medi-
ated signal transduction, as mutation of residues 10–12 (RVP)
or reinsertion of the primate DDIWK motif also impairs signaling
while retaining TRAF6 binding ability. Interestingly, both the
cysteine (Lim et al., 2010) and the arginine (Gupta et al., 2009;
McNatt et al., 2009) residues have been reported to be under
positive selection in primates, and the YCRV motif is only found
in great apes. While the cysteine appears not to be required,
mutation of the R and V to the K and M found in macaques
impaired human tetherin signaling. Furthermore, the context
dependency on the insertion of the glycine-isoluecine pair in
the TM domain that allows gain of function of the rh-tetherin
when fused to the cpz-tetherin tail suggests that a global struc-
tural change in the orientation of the tetherin cytoplasmic tail
was a prerequisite for the acquisition of signaling capacity.
One caveat to the interpretation of these observations is that at
present they have not been performed in the cells from their
cognate primate species. Thus it is unknown whether any of
the context dependency reflects species-specific differences
in downstream cellular partners. Also whether similar signaling
Figure 7. Model for Tetherin’s Proinflamma-
tory Activity
Clustering of tetherin dimers upon restriction
of viral release promotes the recruitment of a
signaling complex that includes TRAF6, and
potentially TRAF2 and Ubc13 dependent on the
YDYCRV motif in tetherin. This leads to the
activation of TAK1, NFkB, and enhanced proin-
flammatory gene expression by the infected cells.
Additionally, in primary HIV-1 target cells, virion
retention and uptake potentially targets restricted
virions to compartments where viral components
are amenable to recognition by TLRs or other
PRRs, thereby indirectly inducing type 1 IFN
responses through the activation of IRFs.
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those tested here remains to be determined.
We propose the following model (Figure 7): tetherin-mediated
virion retention triggers clustering of surface tetherin, targeting
it for endocytic uptake. Coupled to this surface clustering, a
signaling complex containing TRAF6 and perhaps TRAF2 is re-
cruited to the tetherin cytoplasmic tail. What other factors are
present in this complex, or whether it directly interacts with teth-
erin itself or an associated factor, remains to be determined. The
recruited complex then activates TAK1 through the polymeriza-
tion of ubiquitin chains dependent on Ubc13, which in turn leads
to IKK phosphorylation, IkB degradation, and translocation of
NFkB to the nucleus to activate proinflammatory gene expres-
sion. The data presented herein showing that late-domain
mutants of retroviral particles cannot trigger tetherin signaling
indicate that partitioning of tetherin into virions initiates signaling
dependent on the physical separation of budding virions from
the cell membrane. The topology of tetherin dimers that form
the physical tether is not entirely clear (Perez-Caballero et al.,
2009), but the evidence that they can transduce a signal implies
that at least some tetherin dimers must remain with their cyto-
plasmic tails in the cytoplasm. Recently it was demonstrated
that HIV-1 gp41 can also activate TAK1-dependent NFkB sig-
naling to potentiate viral replication in CD4+ T cells (Postler
and Desrosiers, 2012). Whether this underlies the lower level of
responses that we see in wild-type infected cells is unknown,
but may suggest that HIV-1 strikes a balance between maintain-
ing sufficient NFkB activation for viral gene expression and sup-
pressing proinflammatory responses derived from factors such
as tetherin.
While tetherin activated only NFkB reporter genes in 293 cells,
in some donors’ T cells, tetherin-sensitive HIV-1 also inducedCell Host & Microbe 12, 633–644, Ndetectable type 1 interferon secretion.
Again this was tetherin dependent, as
shRNAs against tetherin abolished it.
Since Vpu is not a constituent of incoming
viral particles, this tetherin dependence
of type 1 IFN induction indicates that it
requires a productive round of viral repli-
cation, rather than direct sensing of virion
components from the inoculum. The up-
regulation of IFNb by Vpu() HIV-1 and
HIV-1 Vpu-A14L, but not CXCL10, wasreduced by inhibitory peptides against TRIF, strongly suggesting
TLR3 as the source, which is known to be expressed on some
T cell subsets (Holm et al., 2009). As TLR3 resides primarily in en-
dosomes(Takeuchi and Akira, 2010), these data suggest that
immobilization and endocytic uptake of virions by tetherin may
also lead to augmented recognition of viral components by
membrane-associated PRRs expressed in primary HIV-1 target
cells (for example, virion-associated RNA molecules that may
be liberated upon virion degradation). Low levels of activated
IRF3 could be detected in all virus-infected T cells 48 hr after
infection, contrary to a recent study that suggested IRF3 itself
is degraded by Vpu (Doehle et al., 2012). While purified HIV-1
particles do not directly induce strong inflammatory responses
in most target cells, a recent study has indicated that HIV-in-
fected cells can trigger interferon release from bystanders
through the activation of IRF3 (Lepelly et al., 2011). This appears
to be related to cell-to-cell transmission of fusion-competent
virions, something that could conceivably be further augmented
in this case by tetherin-mediated virion retention (Jolly et al.,
2010). Finally, tetherin’s identification as a regulator of TLR7
activity in plasmacytoid dendritic cells via the inhibitory leuko-
cyte receptor ILT7 suggests that its signaling properties may
have further roles in host-cell pattern recognition (Cao et al.,
2009). The further characterization of virus-induced tetherin
signaling in primary cells and the cellular factors involved will
therefore determine the importance of this attribute in innate
immunity.
Tetherin counteraction is conserved among human and
primate lentiviruses, but the viral protein that performs this
role varies (Le Tortorec et al., 2011). While tetherin restricts
cell-free viral release, it poorly inhibits cell-to-cell viral trans-
fer between CD4+ T cells (Casartelli et al., 2010; Jolly et al.,ovember 15, 2012 ª2012 Elsevier Inc. 641
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in vivo (Jolly and Sattentau, 2004). This suggests that avoid-
ance of tetherin-mediated restriction is required for initial viral
transmission, and/or tetherin’s antiviral activity imposes an
additional inhibition of viral replication in vivo beyond simply
blocking cell-free viral production. For example, accumulation
of virions on cell surfaces by tetherin may promote recogni-
tion of infected cells through the deposition of antibodies
and subsequent clearance by phagocytes. The acquisition
of the coupling of tetherin activity to direct proinflammatory
gene expression via NFkB activation may therefore significantly
augment this by attracting other leukocytes to a site of infec-
tion. The threshold cellular levels of tetherin that can induce
signaling may well be lower than those required for potent
virion retention, providing further impetus for human viruses
to efficiently remove tetherin from the PM. We note with in-
terest that while the Nef and Env countermeasures of SIVs
and HIV-2 do not promote tetherin degradation, HIV-1 Vpu
does (Le Tortorec et al., 2011). Moreover, only Vpu proteins
from the pandemic M Group of HIV-1 have acquired efficient
tetherin counteraction (Sauter et al., 2009). Thus we speculate
that the signaling activity of human tetherin that we have
uncovered contributes to its role in the early innate response
to HIV-1 and other viral infections, and may provide further
selective pressure on enveloped viral pathogens to counteract
its activity. The findings presented herein provide an intriguing
example of a functional activity within a mediator of intrinsic
viral defense that may have arisen to augment its overall
potency in response to pressure by viral proteins that target
its antiviral activity.EXPERIMENTAL PROCEDURES
Plasmids and Cells
The molecular clones of HIV-1 NL4.3 and derived Vpu mutants have been
described previously (Neil et al., 2006; Vigan and Neil, 2010). Tetherin mutants
and species orthologs were made in pCR3.1 by standard molecular biological
methods. Chimpanzee tetherin was provided by G. Towers (UCL). pCR3.1-
GFP-EBoV Vp40, pMLVNCS (MLV), pMLVp6py, and pMLVNCSDpy plasmids
were provided by J. Martin-Serrano (KCL) (Martin-Serrano et al., 2004). The
NFkB-dependent 3xkB-pCONA-FLuc reporter construct, the CMV-RLuc
control plasmid, and human TRAF6 cDNAs were provided by A. MacDonald
(Mankouri et al., 2010) (University of Leeds). TRAF6 was subcloned with an
N-terminal HA tag into pCR3.1. The MAVS expression vector was provided
by J. Luban (University of Geneva) and the IFNb-promoter luciferase vectors
by M. Malim.
293 and 293T cells were obtained from the ATCC, while the reporter cell line
HeLa-TZMbl was provided by John Kappes through the NIH AIDS Reagents
Repository Program (ARRP). All adherent cells were maintained in DMEM sup-
plemented with 10% fetal calf serum (FCS) and gentamicin. Derivatives stably
expressing human tetherin or mutants thereof were produced by transducing
the cells with MLV-based retroviral vectors packaging a pLHCX (Clontech)
vector genome encoding the tetherin construct and selecting the cells in
hygromycin (Invitrogen).
Peripheral blood mononuclear cells were isolated from freshly drawn whole
blood on Lymphoprep (Axis-Shield). CD4+ T cells were then purified using an
Untouched CD4+ T cell Dynabead kit (Invitrogen), and then activated for 48 hr
with anti-CD3/anti-CD28 Dynabeads (Invitrogen) prior to use and cultured in
RPMI/10% FCS/gentamicin and 30 U/ml recombinant IL-2. CD4 and tetherin
expression were determined by flow cytometry using anti-CD4 APC (Becton
Dickinson) or anti-human BST2-PE (eBiosciences). HIV-1 infection of T cells
was monitored by flow cytometry using an intracellular anti-p24-PE (Beckam
Coulter) staining.642 Cell Host & Microbe 12, 633–644, November 15, 2012 ª2012 ElsReporter Gene Assays
For transient reporter gene assays, 105 293 cells were transfectedwith 50 ng of
pCR3.1 tetherin plasmid or control pCR3.1 YFP in combination with 10 ng of
3xkB-pCONA-FLuc or IFNb-luciferase reporter and 5 ng pCMV-RLuc. Forty-
eight hours after transfection, firefly andRenilla luciferase activity in cell lysates
was measured using a dual luciferase kit (Promega) and normalized. For anti-
body crosslinking experiments, 293 or 293THN cells were transfected with
10 ng of 3xkB-pCONA-FLuc and 5 ng pCMV-RLuc. Six hours later, the cells
were treated with a 1:100 dilution of rabbit-anti-BST2 polyclonal Ab (Miyagi
et al., 2009) (provided by K. Strebel through the NIH ARPP) followed by
addition of a donkey anti-rabbit secondary. Cell lysates were taken at various
time points thereafter and subjected to SDS-PAGE and western blot with
rabbit anti-IkB-a (Cell Signaling), rabbit monoclonal anti-Phospho-IKKa/b
(Ser176/180-clone 16A6, Cell Signaling), rabbit monoclonal anti-IRF3 (clone
D83B9, Cell Signaling), rabbit monoclonal anti-Phospho-IRF3 (clone S396,
Cell Signaling), rabbit anti-RelA, and rabbit anti-hsp90 (Santa Cruz Biotechnol-
ogies) and visualized either by Li-Cor apparatus using fluorophore-conjugated
secondary antibody (IRDye 800Goat anti-rabbi IRDye 680Goat anti-mouse) or
by ImageQuant using anti-rabbit HRP-linked secondary antibodies (NEB, UK).
Luciferase activities were determined at 24 hr posttreatment.
For viral-mediated reporter gene assays, 293 or 293THN cells were trans-
fected with 10 ng of 3xkB-pCONA-FLuc (or IFNb luciferase reporter) and
5 ng pCMV-RLuc in combination with 500 ng pNL4.3, pNL4.3 Vpu mutant,
pCR3.1-GFP-EBoV VP40), MLV, MLVDPY, or MLVDPY/p6 (Martin-Serrano
et al., 2001. For experiments with MLV or derivatives, 200 ng of pCNCG and
100 ng of pVSV-G were cotransfected. Luciferase activities were measured
48 hr posttransfection. Infectivity of viral supernatants and biochemical anal-
ysis of cell lysates and viral particles were performed as described below in
‘‘Virus Stocks and Release Assays.’’
For transient knockdown of signaling components, 105 cells were seeded
per well of a 24-well plate, and 6 hr later the cells were transfected with
50 pmol of siRNA in complex with Dharmofect-1 (Dharmacon). Forty-eight
hours later, cells were reseeded and 6 hr later cotransfected with a second
dose of siRNA alongside reporter constructs as per the transient reporter
gene assays. The following siRNAs were used: from QIAGEN, MAP3K7_5
(TAK1) (SI00300741); TRAF2_7 (SI03096009) for TRAF2; TRAF6_7 and _8
(SI03046043 and SI03050145) for TRAF6; Dharmacon ON-TARGETplus
SMARTpools for human AP2M1 (L-008170-00-0005) for AP2 and human
UBE2N (L-003920-00-0005) for Ubc13 and siControl nontargeting pool (D-
001810-10-20) as the siRNA control. Protein knockdowns were verified by
western blot using the following antibodies: rabbit anti-TAK1, rabbit anti-
TRAF2 (c192), rabbit anti-Ubc13 (Cell Signaling Technology), rabbit anti-
TRAF6 (H274, Santa Cruz), and mouse anti-AP2m1 (BD Biosciences).
Virus Stocks and Release Assays
HIV-1 NL4.3 and Vpu mutant viral stocks were produced in 293T cells by tran-
sient transfection, and endpoint titers were determined onHeLa-TZM indicator
cells as described previously (Le Tortorec and Neil, 2009). For primary cell
infections, viral stocks were treated for 2 hr with 10 U/ml DNase-I (Roche)
and then concentrated by ultracentrifugation through a 20% sucrose/PBS
cushion (30,000 rpm on a Sorvall SW41 rotor for 90 min) and resuspended in
RPMI.
For viral release assays, CD4+ T cells were infected with HIV-1 NL4.3 or Vpu
mutant at the required multiplicity, and washed. Forty-eight hours later, cell
lysates and filtered viral supernatants were harvested. The infectivity of viral
supernatants was determined on HeLa-TZMbl cells as described (Le Tortorec
and Neil, 2009). MLV titers were determined by transducing 293T cells and
enumerating the GFP-positive cells by FACS 48 hr later. HIV-1 particle release
was determined by quantitative western blot, as described (Vigan and Neil,
2010).
Primary Cell Infections
53 105 activated CD4+ T cells were infected at a multiplicity of infection (moi)
of 5 to ensure >90% p24+ cells 48 hr postinfection. Cells and supernatants
were then harvested and assayed for viral gene expression, and virus particle
production as described above. Cells were also harvested for total RNA and
supernatants for cytokine production. When required, equal amounts of acti-
vated CD4+ T cells were transduced with lentiviral vectors (pCSGW) encodingevier Inc.
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Tetherin Senses HIV AssemblyU6-driven shRNA-GFP, 50-GUUCAUCUGCACCACCGGCAAGCUUCGGCUU
GCCGGUGGUGCAGAUACUU-30; or shRNA-THN, 50-GGAGTTCTGGTG
TTCCTGATTATTTCGATGATCAGGAGCACCGAATTCC-30, provided by G.
Towers (UCL) at an input equivalent to a moi of 5 when titered on 293T cells.
The transduced cells were infected 24 hr later and harvested as described
above. Surface tetherin levels were determined by flow cytometry at 48 hr
posttransduction. For TLR inhibition studies, infected cells were cultured in
the presence of 40 mM of control, TRIF, and MyD88-inhibitory peptides
(Invivogen).
Quantitative RT-PCR
Total RNA was isolated and purified from transfected or infected cells using a
QIAGEN RNeasy kit, and 50 ng of RNA was reverse transcribed by random
hexamer priming using a High Capacity cDNA Reverse Transcription kit
(ABI). Of the reaction, 5 ml was subjected to quantitative PCR using ABI
primer/probe sets for human Cxcl10, IL6, Ifnb, and Gapdh in an ABIPrism
7900HT Sequence Detections System. Ct data was processed relative to
the GAPDH control using the ABI RQ Manager 1.2 software.
Cytokine Production
Supernatants for infected T cells were analyzed for CXCL10 and IL-6 protein
levels using specific Quantikine ELISAs (R+D Systems). Levels of bioactive
type-I IFN were determined using HEK-Blue indicator cells (InVivoGen).
Immunoprecipitations
293 cells were transfected with 700 ng of HA-TRAF6 in combination with equal
quantities of pCR3.1-GFP or pCR3.1 tetherin constructs. Forty-eight hours
posttransfection, cells were lysed in 1% digitonin in 50 mM Tris-HCL (pH
7.4)/150 mM NaCl with protease inhibitors (Roche) and N-ethymaleimide.
Postnuclear supernatants were immunoprecipitated with 5 mg of anti-HA.11
mAb (Covance) and protein G agarose beads (Invitrogen). Cell lysates and
IPs were subjected to SDS-PAGE and western blots performed using rabbit
anti-HA (Rockland) and rabbit anti-BST2 antibodies and visualized by Image-
Quant using HRP-linked anti-rabbit secondary Abs (NEB, UK).
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